Trustpilot Group (LON:TRST) Trading 13.3% Higher Following Insider Buying Activity

Trustpilot shares surged 13.3% intraday to a high of GBX 150 (last GBX 146.40) on heavy volume of ~8.86M shares (up 137% vs. the 3.74M average) following a string of insider purchases (Zillah Byng‑Thorne 108,116 shares at GBX 138; Hanno Damm 50,000 at GBX 140; Joe Hurd 718 at GBX 140) and positive analyst action. Deutsche Bank raised its target to GBX 343 (buy) and UBS reaffirmed a GBX 400 buy target; MarketBeat shows 3 buys/1 sell and an average target of GBX 340.75. Company fundamentals show a market cap of £584.44m, negative P/E (-1.24), debt/equity 41.16 and 50-/200‑day MAs of GBX 197.45/219.58; the board also authorized a buyback on Sept. 16 (authorization details appear anomalous in the filing). These developments suggest short‑term bullish momentum driven by insider confidence and analyst support despite negative earnings metrics.

Analysis

Market Structure: The 13.3% intraday jump to GBX 150 on 137% higher volume (8.86m vs 3.74m avg) signals a short-term liquidity imbalance driven by headline insider buys (Zillah Byng‑Thorne 108k @ GBX 138). Direct beneficiaries are long‑bias retail and derivatives flows in TRST.L; competitors of review platforms see little immediate effect. With analyst mean target GBX ~341 (implies +≈133% upside) versus current GBX ~146 and a negative P/E, price action reflects sentiment repricing rather than fundamentals changing overnight.

Risk Assessment: Tail risks include regulatory action on fake/review moderation (consumer protection/GDPR fines), platform credibility shocks, or unexpected dilution from options issuance — each could cut market cap by 30–60% in a stress scenario. Short term (days) expect mean‑reversion or continuation based on flow; medium (3–12 months) depends on re‑acceleration of revenue and EBITDA margin; long term (1–3 years) hinges on sustained MAU growth and path to profitability given quick ratio 1.71 but elevated debt/equity ~41.

Trade Implications: Tactical entry should size conservatively — the trade is idiosyncratic long with defined risk via options. Prefer staged accumulation in TRST.L between GBX 130–160 targeting GBX 340 (scale out at 220, 280) while hedging market beta; use calendar 12–18 month call spreads to express asymmetric upside. Avoid levering outright until upcoming quarterly metrics confirm GMV/review monetization improvements.

Contrarian Angles: Consensus is missing execution risk — analysts’ lofty targets assume margin improvement and no regulatory shocks; insiders’ purchases are meaningful for signaling but modest in capital terms (Zillah ~£149k). The pop could be overdone intraday; a durable re‑rating requires visible buyback execution (clarify authorized amount) and 2 consecutive quarters of revenue acceleration (>20% YoY) or the move will likely fade. Watch insider cadence, buyback filings and review quality KPIs over the next 30–90 days.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Trustpilot (TRST.L) via cash equity with staggered buys at GBX 130, 145, 160; set a hard stop at GBX 110 and scale out if price reaches GBX 220 (take 50%) and GBX 340 (take remaining).
• Buy a defined‑risk call spread to express upside: Jun 2026 TRST.L 120/320 call spread sized to 1% of NAV (max loss = premium); roll or unwind if spread value doubles or if next two quarterly reports miss revenue or MAU guidance.
• For existing holders, buy a 9–12 month protective put (e.g., Nov 2025 ~80–100 GBX strike depending on premium) to cap downside to ~30–40% if regulatory or credibility issues surface within 6 months.
• Run a market‑neutral pair: long TRST.L (as above) and short 0.5x notional exposure to FTSE 100 index (UKX) to remove ~50% market beta; rebalance after 30–90 days and tighten stops if TRST underperforms index by >15% in that window.
• Monitor closely over next 30–60 days: (1) company filing/notice clarifying authorized buyback size and execution, (2) insider buy cadence and size (>=500k total in 30 days is bull confirmation), and (3) next earnings for revenue growth >20% YoY and ARR/margin beat — only scale to 4–5% if two of three are satisfied.